Outset Medical(US:OM) Prnewswire·2025-11-28 20:06Company Overview - Outset Medical Inc. is a medical technology company based in San Jose, California, known for developing and producing the Tablo Hemodialysis System [3]. Allegations and Financial Performance - On November 10, 2025, Outset Medical reported its third-quarter 2025 financial results, showing non-GAAP earnings per share of –$0.69, which missed consensus estimates by $0.03. The revenue was reported at $29.43 million, falling short of expectations by $1.27 million [4]. - The company also revised its full-year 2025 revenue guidance down to a range of $115–$120 million from the previous range of $122–$126 million, citing delays in several anticipated opportunities [4]. Stock Market Reaction - Following the financial announcement, Outset Medical's stock price dropped by $5.85 per share, or 48.47%, closing at $6.22 per share on November 11, 2025 [5].